Key facts
- This page summarizes Sandra Milligan's Form 4 filing for Organon & Co. (OGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 May 2023, 18:43.
Sandra Milligan - 04 May 2023 Form 4 Insider Report for Organon & Co. (OGN)
- Reporting relationship
- Head of Research & Development
- Issuer ticker
- OGN
- Reported as of
- 04 May 2023
- Net transaction value
- -$52,552
- SEC form
- 4
- Accepted by SEC
- 08 May 2023, 18:43:51 UTC
- Prior SEC filing
- 03 May 2023
- Next SEC filing
- 09 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandra Milligan filed Form 4 for Organon & Co. (OGN) on 08 May 2023.
Change
- Previous filing in this sequence was filed on 03 May 2023.
- Current net transaction value: -$52,552.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OGN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,984
- Change %
- +19%
- Price
- Shares after
- 30,767
- Date
- 04 May 2023
- Ownership
- Direct
- Footnotes
- F1
OGN
transaction
Common Stock
Tax liability
- Transaction value
- $52,552
- Shares
- -2,168
- Change %
- -7%
- Price
- $24.24
- Shares after
- 28,599
- Date
- 04 May 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,984
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 4,984
- Date
- 04 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,989
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024.